Who owns Recro Pharma?
- CUSIP Number: 75629f109
Tip: Access positions for across all investors
Analyze quarterly positions in Recro Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Recro Pharma stock
Who bought or sold Recro Pharma this quarter?
There are no current stakeholders of Recro Pharma.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Recro Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vanguard Group | Mar 2024 | 3.1M | $3.3M |
| Vazirani Asset Management | Mar 2024 | 750k | $810k |
| Skandinaviska Enskilda Banken AB | Mar 2024 | 717k | $775k |
| EHP Funds | Mar 2024 | 500k | $540k |
| BlackRock | Mar 2024 | 492k | $531k |
| State Street Corporation | Mar 2024 | 316k | $341k |
| Bridgeway Capital Management | Mar 2024 | 203k | $219k |
| Northern Trust | Mar 2024 | 200k | $217k |
| Morgan Stanley | Mar 2024 | 47k | $51k |
| Two Sigma Securities | Mar 2024 | 28k | $30k |
| Virtu Financial | Mar 2024 | 25k | $27k |
| Titleist Asset Management | Mar 2024 | 23k | $25k |
| Two Sigma Investments | Mar 2024 | 20k | $21k |